• 
  Paul Marcoux. RET-altered Induced Pluripotent Stem Cells (iPSCs) for modeling Hematopoiesis and Non-Small Cell Lung Cancer (NSCLC). Cancer. Université Paris-Saclay, 2023. English. ⟨NNT : 2023UPASQ062⟩. ⟨tel-04415412⟩
• 
  Lucie Portier, Christophe Desterke, Diana Chaker, Noufissa Oudrhiri, Afag Asgarova, et al.. iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression. International Journal of Molecular Sciences, 2021, 22 (3), pp.1227. ⟨10.3390/ijms22031227⟩. ⟨hal-04033908⟩
• 
  Jusuf Imeri. Induced Pluripotent Stem Cells (iPSC) in Chronic Myeloid Leukemia (CML) : Modelling Blast Crisis and Designing a CAR-Cell Therapy Model. Cancer. Université Paris-Saclay, 2022. English. ⟨NNT : 2022UPASQ066⟩. ⟨tel-04360888⟩
• 
  Christophe Desterke, Emma Cosialls, Yao Xiang, Rima Elhage, Clémence Duruel, et al.. Adverse Crosstalk between Extracellular Matrix Remodeling and Ferroptosis in Basal Breast Cancer. Cells, 2023, 12 (17), pp.2176. ⟨10.3390/cells12172176⟩. ⟨hal-04295124⟩
• 
  Yingying Zhu, Julien Saint-Pol, Viet Nguyen, Eric Rubinstein, Claude Boucheix, et al.. The Tetraspanin Tspan8 Associates with Endothelin Converting Enzyme ECE1 and Regulates Its Activity. Cancers, 2023, 15, ⟨10.3390/cancers15194751⟩. ⟨hal-04247136⟩

55